Targeting cancer-intrinsic protein neddylation bypasses the loss of JAK/STAT signaling and overcomes acquired resistance to immunotherapy

Imagine your body as a bustling city with a highly trained police force: the immune system. Its job is to patrol the streets, spot criminals (cancer cells), and take them out. To do this, the police need a clear "Wanted" poster on the criminal's back, a signal that says, "Hey, I'm bad, stop me!" In the world of cancer, this signal is often a protein called MHC-I. But sometimes, cancer cells get clever. They strip off their "Wanted" posters or jam the radio frequencies the police use to talk to each other (a system called JAK/STAT signaling). When this happens, the cancer becomes invisible to the immune system, and treatments designed to wake up the police (immunotherapy) stop working. This is known as "acquired resistance," and it's a major roadblock for patients who initially respond to treatment but then stop getting better.

Scientists have been trying to figure out how to trick these invisible criminals back into the spotlight. They know that if they can force the cancer to show its "Wanted" poster again, or if they can bypass the broken radio, the police might be able to do their job. The big question is: what is the master switch inside the cancer cell that, if flipped, could restore the signal even when the usual radio is broken? This paper dives deep into that mystery, looking for a hidden lever that cancer cells use to hide, and seeing if pulling that lever could make immunotherapy work again.

---

The Invisible Cloak and the Magic Switch

In this study, researchers set out to solve a frustrating puzzle: why do some melanoma patients stop responding to immunotherapy? They started with a specific pair of cancer cells taken from the same patient. The first batch (M420) was "treatment-experienced," meaning it hadn't seen the drugs yet. The second batch (M464) was the "survivor" that had learned to dodge the treatment. The secret weapon of the survivor? It had lost a key part of its radio receiver, a gene called JAK2. Without this, the cancer cell couldn't hear the immune system's commands, couldn't put up its "Wanted" poster, and stayed invisible.

The team decided to play a game of "find the weak spot." They used a massive genetic screen, which is like testing thousands of different keys to see which one unlocks the door to the cancer's defenses. They grew these resistant cancer cells in a dish alongside human immune cells and added a drug that blocks the "stop" signal (PD1 blockade). Then, they systematically broke different genes in the cancer cells to see which break made the immune system attack again.

The winner of this search wasn't a gene you'd expect. It was a process called neddylation. Think of neddylation as a factory assembly line inside the cell that tags other proteins with a tiny, sticky note called NEDD8. Usually, this assembly line helps the cancer cell grow fast and stay hidden. But the researchers found that if they smashed the main machine of this assembly line (a gene called UBA3), the cancer cells suddenly became visible again.

How the Trick Works

When the researchers broke the neddylation machine, something magical happened inside the cancer cell. Even though the radio receiver (JAK2) was still broken, the cell started shouting "I'm here!" anyway. How?

The paper suggests that the neddylation machine usually keeps a security guard protein called cGAS locked away in a cage. cGAS is like a motion detector that senses trouble (like DNA damage) and sounds an alarm. When the neddylation machine was destroyed, the cage broke open, and cGAS was free to stick to the cell's DNA (chromatin). This triggered a loud alarm that bypassed the broken radio entirely.

This alarm didn't just wake up the cancer cell; it changed the neighborhood. It attracted a fresh wave of immune "police," specifically dendritic cells and natural killer (NK) cells. These cells are the heavy hitters that can eat cancer cells directly. In the lab, when the researchers broke the neddylation machine, the immune cells released a weapon called granzyme B (which punches holes in cancer cells) and started multiplying.

Testing the Theory in Mice

To see if this worked in a living body, the researchers moved to mice with breast cancer. They created tumors that were super-resistant because they lacked the radio (JAK1 or JAK2) and even the "Wanted" poster (B2m). These tumors usually ignore immunotherapy completely.

But when the researchers removed the neddylation machine from these super-resistant tumors and gave the mice the PD1 drug, the results were stunning.

• In mice with tumors that lacked JAK2, the treatment worked much better, and the mice lived longer.
• In mice with tumors that lacked both JAK2 and the "Wanted" poster (B2m), the treatment was so effective that half of the mice became completely tumor-free.

The researchers used a high-tech microscope (single-cell RNA sequencing) to look inside the tumors. They found that the tumors without the neddylation machine were packed with pro-inflammatory immune cells. The cancer cells were essentially ringing the doorbell so loudly that the immune system couldn't ignore them, even if the doorbell wire was cut.

The Human Connection

Finally, the team looked at real data from human melanoma patients. They calculated a "neddylation score" for the cancer cells in patient tumors. They found that patients whose tumors had low neddylation scores were more likely to respond to immunotherapy. These patients also had more dendritic cells (the immune system's scouts) hanging out in their tumors. This suggests that the mechanism they found in the lab and in mice might be happening in people, too.

The Bottom Line

This paper doesn't claim to have a cure ready for the pharmacy tomorrow. Instead, it offers a new map. It shows that even when cancer breaks the usual communication lines (JAK/STAT), there is a backup system (cGAS) that can be activated by targeting the neddylation assembly line. By breaking this specific part of the cancer's machinery, we might be able to force the cancer to reveal itself, allowing the immune system to finish the job. It's a promising new strategy to overcome the stubborn resistance that stops immunotherapy from saving more lives.